ARA-290 10mg

ARA-290 10mg
$30.00

ARA-290 is a small peptide derived from the structure of erythropoietin (EPO) and designed to selectively engage tissue-protective signaling pathways without the hematopoietic effects typically associated with EPO. In research settings, ARA-290 is primarily investigated for its interaction with the so-called innate repair receptor (IRR) and tissue-protective receptor (TPR), where it has been shown in preclinical and early clinical studies to influence inflammatory signaling, vascular repair mechanisms, neuropathic pain pathways, and wound-healing processes.

For research use only — not for human consumption.

 

Specifications

 

  • Compound: ARA-290

  • Category/Target: Erythropoietin (EPO) and designed to selectively engage tissue-protective signaling pathways without the hematopoietic effects typically associated with EPO.

  • Form / appearance: Lyophilized powder, white to off-white

  • Amount: 10mg per vial

  • Purity: ≥99%

  • Storage (lyophilized): Cool, dry place away from light

  • Storage (after reconstitution): Refrigerate; use promptly per internal SOP

 

What’s Included

 

  • 1 × ARA-290 10mg vial (no diluent/solvent)

 

Handling

 

Use an appropriate, compatible solvent per your protocol and laboratory SOPs. Confirm solubility in the intended vehicle and, if required, pass through a sterile filter (0.22 µm) under aseptic technique.

Research Snapshot

 

  • Preclinical and translational research has examined ARA-290 in models of vascular injury, islet transplantation, autoimmune conditions, neuropathic pain, and small fiber neuropathy, making it a versatile tool for studying tissue protection and immune modulation.

 

Compliance

 

For research use only. Not for human consumption.

Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.